134 related articles for article (PubMed ID: 36724402)
41. Assessment of Oncology Practice Billing Claims for Supplementing Chemotherapy: A Pilot Study in the Georgia SEER Cancer Registry.
Howlader N; Ward KC; Warren JL; Campbell DS; Coyle L; Mariotto AB
J Natl Cancer Inst Monogr; 2020 May; 2020(55):82-88. PubMed ID: 32412070
[TBL] [Abstract][Full Text] [Related]
42. Sampling coverage of the Arkansas all-payer claims database by County's persistent poverty designation.
Li C; Peng C; DelNero P; Saini M; Schootman M
Health Serv Res; 2024 Jun; ():. PubMed ID: 38880660
[TBL] [Abstract][Full Text] [Related]
43. Investigating confounders of the association between survival and adjuvant radiation therapy after breast conserving surgery in a sample of elderly breast Cancer patients in Appalachia.
Camacho F; Anderson R; Kimmick G
BMC Cancer; 2019 Dec; 19(1):1228. PubMed ID: 31847855
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
Gold HT; Do HT
Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
[TBL] [Abstract][Full Text] [Related]
45. Effectiveness of radiation for prevention of mastectomy in older breast cancer patients treated with conservative surgery.
Albert JM; Pan IW; Shih YC; Jiang J; Buchholz TA; Giordano SH; Smith BD
Cancer; 2012 Oct; 118(19):4642-51. PubMed ID: 22890779
[TBL] [Abstract][Full Text] [Related]
46. The utility of Medicare claims data for measuring cancer stage.
Cooper GS; Yuan Z; Stange KC; Amini SB; Dennis LK; Rimm AA
Med Care; 1999 Jul; 37(7):706-11. PubMed ID: 10424641
[TBL] [Abstract][Full Text] [Related]
47. An approach to identifying incident breast cancer cases using Medicare claims data.
Freeman JL; Zhang D; Freeman DH; Goodwin JS
J Clin Epidemiol; 2000 Jun; 53(6):605-14. PubMed ID: 10880779
[TBL] [Abstract][Full Text] [Related]
48. Claims data linked to hospital registry data enhance evaluation of the quality of care of breast cancer.
Meguerditchian AN; Stewart A; Roistacher J; Watroba N; Cropp M; Edge SB
J Surg Oncol; 2010 Jun; 101(7):593-9. PubMed ID: 20461766
[TBL] [Abstract][Full Text] [Related]
49. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
Dinan MA; Mi X; Reed SD; Lyman GH; Curtis LH
JAMA Oncol; 2015 Nov; 1(8):1098-109. PubMed ID: 26313372
[TBL] [Abstract][Full Text] [Related]
50. External validation of a claims-based algorithm for classifying kidney-cancer surgeries.
Miller DC; Saigal CS; Warren JL; Leventhal M; Deapen D; Banerjee M; Lai J; Hanley J; Litwin MS
BMC Health Serv Res; 2009 Jun; 9():92. PubMed ID: 19500395
[TBL] [Abstract][Full Text] [Related]
51. Variation in receipt of radiation therapy after breast-conserving surgery: assessing the impact of physicians and geographic regions.
Feinstein AJ; Soulos PR; Long JB; Herrin J; Roberts KB; Yu JB; Gross CP
Med Care; 2013 Apr; 51(4):330-8. PubMed ID: 23151590
[TBL] [Abstract][Full Text] [Related]
52. Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?
Keating NL; Kouri E; He Y; Weeks JC; Winer EP
Med Care; 2009 Jul; 47(7):765-73. PubMed ID: 19536008
[TBL] [Abstract][Full Text] [Related]
53. Survival disadvantage among Medicaid-insured breast cancer patients treated with breast conserving surgery without radiation therapy.
Foley KL; Kimmick G; Camacho F; Levine EA; Balkrishnan R; Anderson R
Breast Cancer Res Treat; 2007 Jan; 101(2):207-14. PubMed ID: 16838114
[TBL] [Abstract][Full Text] [Related]
54. Agreement of diagnosis and its date for hematologic malignancies and solid tumors between medicare claims and cancer registry data.
Setoguchi S; Solomon DH; Glynn RJ; Cook EF; Levin R; Schneeweiss S
Cancer Causes Control; 2007 Jun; 18(5):561-9. PubMed ID: 17447148
[TBL] [Abstract][Full Text] [Related]
55. Intensity modulated radiation therapy following lumpectomy in early-stage breast cancer: Patterns of use and cost consequences among Medicare beneficiaries.
Halasz LM; Patel SA; McDougall JA; Fedorenko C; Sun Q; Goulart BHL; Roth JA
PLoS One; 2019; 14(9):e0222904. PubMed ID: 31568536
[TBL] [Abstract][Full Text] [Related]
56. Geographical Variation in Health Spending Across the US Among Privately Insured Individuals and Enrollees in Medicaid and Medicare.
Cooper Z; Stiegman O; Ndumele CD; Staiger B; Skinner J
JAMA Netw Open; 2022 Jul; 5(7):e2222138. PubMed ID: 35857326
[TBL] [Abstract][Full Text] [Related]
57. Validation of a Medicare Claims-based Algorithm for Identifying Breast Cancers Detected at Screening Mammography.
Fenton JJ; Onega T; Zhu W; Balch S; Smith-Bindman R; Henderson L; Sprague BL; Kerlikowske K; Hubbard RA
Med Care; 2016 Mar; 54(3):e15-22. PubMed ID: 23929404
[TBL] [Abstract][Full Text] [Related]
58. Sensitivity of administrative claims to identify incident cases of lung cancer: a comparison of 3 health plans.
Ramsey SD; Scoggins JF; Blough DK; McDermott CL; Reyes CM
J Manag Care Pharm; 2009 Oct; 15(8):659-68. PubMed ID: 19803555
[TBL] [Abstract][Full Text] [Related]
59. The Effect of Payer Type on Patient-Reported Outcomes in Total Joint Arthroplasty Is Modulated by Baseline Patient Characteristics.
Halawi MJ; Cote MP; Savoy L; Williams VJ; Lieberman JR
J Arthroplasty; 2019 Jun; 34(6):1072-1075. PubMed ID: 30797645
[TBL] [Abstract][Full Text] [Related]
60. Receipt of locoregional therapy among young women with breast cancer.
Freedman RA; Virgo KS; Labadie J; He Y; Partridge AH; Keating NL
Breast Cancer Res Treat; 2012 Oct; 135(3):893-906. PubMed ID: 22949130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
